• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化肝脏中的局灶性病变:动脉性门静脉造影磁共振成像与钆增强动态磁共振成像的比较

Focal lesions in cirrhotic liver: comparing MR imaging during arterial portography with Gd-enhanced dynamic MR imaging.

作者信息

Yu J S, Kim K W, Lee J T, Yoo H S

机构信息

Department of Diagnostic Radiology and the Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Yonsei Med J. 2000 Oct;41(5):546-55. doi: 10.3349/ymj.2000.41.5.546.

DOI:10.3349/ymj.2000.41.5.546
PMID:11079613
Abstract

The purpose of this study was to document the additional value of MR imaging during arterial portography (MRAP) in patients examined with intravenous contrast-enhanced dynamic MR imaging for the assessment of focal lesions in patients with cirrhosis or chronic viral hepatitis. The MR images of 24 patients with 39 hepatocellular carcinomas and 18 benign hepatocellular nodules examined with dynamic MR imaging and MRAP within a 14-day interval were retrospectively reviewed. For 39 hepatocellular carcinomas, MRAP revealed 37 perfusion defects (95%), while dynamic MR imaging demonstrated 35 occurrences of nodular contrast-enhancement (90%) on arterial dominant phases. Among the 11 benign nodules misinterpreted as hepatocellular carcinoma due to their high signal intensities on arterial-dominant phases of dynamic MR imaging, eight (73%) showed intratumoral portal venous perfusion on MRAP and were regarded as benign nodules. As a result of its high sensitivity and its potential ability to enable differentiation of benign and malignant hepatocellular nodules, MRAP can be added to dynamic MR imaging for planning future management in patients with equivocal hepatocellular nodules in the cirrhotic liver.

摘要

本研究的目的是记录在接受静脉注射对比剂增强动态磁共振成像(MRI)检查以评估肝硬化或慢性病毒性肝炎患者局灶性病变的患者中,动脉期门静脉造影磁共振成像(MRAP)的附加价值。回顾性分析了24例患者的MR图像,这些患者在14天内接受了动态MRI和MRAP检查,其中有39个肝细胞癌和18个良性肝细胞结节。对于39个肝细胞癌,MRAP显示37个灌注缺损(95%),而动态MRI在动脉期显示35个结节性对比增强(90%)。在11个因动态MRI动脉期高信号强度而被误诊为肝细胞癌的良性结节中,8个(73%)在MRAP上显示瘤内门静脉灌注,并被视为良性结节。由于其高敏感性以及能够区分良性和恶性肝细胞结节的潜在能力,MRAP可添加到动态MRI中,用于规划肝硬化肝脏中肝细胞结节不明确患者的未来治疗方案。

相似文献

1
Focal lesions in cirrhotic liver: comparing MR imaging during arterial portography with Gd-enhanced dynamic MR imaging.肝硬化肝脏中的局灶性病变:动脉性门静脉造影磁共振成像与钆增强动态磁共振成像的比较
Yonsei Med J. 2000 Oct;41(5):546-55. doi: 10.3349/ymj.2000.41.5.546.
2
MR imaging during arterial portography for assessment of hepatocellular carcinoma: comparison with CT during arterial portography.动脉性门静脉造影磁共振成像用于评估肝细胞癌:与动脉性门静脉造影CT的比较
AJR Am J Roentgenol. 1998 Jun;170(6):1501-6. doi: 10.2214/ajr.170.6.9609162.
3
Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.直径小于 2 厘米的肝硬化患者动脉期增强仅有结节:钆贝葡胺增强磁共振成像诊断肝细胞癌的预测因素。
J Magn Reson Imaging. 2013 Apr;37(4):892-902. doi: 10.1002/jmri.23873. Epub 2012 Oct 23.
4
T2-weighted MR imaging in the assessment of cirrhotic liver.T2加权磁共振成像在肝硬化肝脏评估中的应用
Radiology. 2004 Mar;230(3):637-44. doi: 10.1148/radiol.2303020921. Epub 2004 Jan 22.
5
Homogeneous enhancement of hepatic parenchyma: MR imaging during arterial portography versus CT during arterial portography.肝实质均匀强化:动脉门静脉造影磁共振成像与动脉门静脉造影CT的比较
Abdom Imaging. 1998 Jan-Feb;23(1):51-5. doi: 10.1007/s002619900284.
6
Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.小的富血管性肝细胞癌:动态磁共振成像中门静脉期和延迟期的价值有限
Acta Radiol. 2008 Sep;49(7):735-43. doi: 10.1080/02841850802120045.
7
Differentiation of small (≤2 cm) hepatocellular carcinomas from small benign nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images.基于钆塞酸二钠增强磁共振成像和扩散加权磁共振成像鉴别肝硬化肝脏中直径≤2cm的小肝细胞癌与小良性结节
Abdom Imaging. 2015 Jan;40(1):64-75. doi: 10.1007/s00261-014-0188-8.
8
Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.超顺磁性氧化铁增强 MRI 成像在肝硬化肝脏肝细胞癌无创成像诊断中的附加价值。
Invest Radiol. 2009 Dec;44(12):800-7. doi: 10.1097/RLI.0b013e3181bc271d.
9
Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.肝硬化肝脏磁共振成像中仅在肝动脉期出现的小(≤20毫米)强化病变的重要性:与整个切除肝脏的评估和比较
Radiology. 2005 Dec;237(3):938-44. doi: 10.1148/radiol.2373041364.
10
Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.肝硬化肝脏中肝细胞癌的检测:钆与超顺磁性氧化铁增强磁共振成像的比较
AJR Am J Roentgenol. 1999 Jun;172(6):1547-54. doi: 10.2214/ajr.172.6.10350287.